Seeking Alpha

Cleveland BioLabs (CBLI) gets a lift during the post-session after Cantor Fitzgerald initiated...

Cleveland BioLabs (CBLI) gets a lift during the post-session after Cantor Fitzgerald initiated the shares late in the day with a Buy rating and a hefty $4 price target. Cantor says the stock has been depressed by several overhangs that have caused it to lag its peers. Once that pressure is eliminated, the shares should trade at a higher valuation more closely aligned to its peers. Shares +6.7% AH.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)